← Back to Search

Home-Based Cognitive Training for Post-Traumatic Epilepsy (HOBSCOTCHPTE Trial)

N/A
Recruiting
Led By Barbara C. Jobst, MD, Dr. Med.
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of post traumatic epilepsy, with controlled or uncontrolled seizures
Subjective memory complaints
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months, 6 months
Awards & highlights

HOBSCOTCHPTE Trial Summary

This trial will test whether the HOBSCOTCH-PTE program can improve quality of life and cognitive function in people with post traumatic epilepsy, as well as reduce caregiver burden.

Who is the study for?
This trial is for adults over 18 with post-traumatic epilepsy (PTE), who may have controlled or uncontrolled seizures and memory issues. Participants must not have changed their epilepsy or antidepressant medications in the last month, except for brief pauses for EEG tests. They should be able to read English and have access to a phone and internet.Check my eligibility
What is being tested?
The HOBSCOTCH-PTE program is being tested to see if it can help improve life quality and brain function in people with PTE, as well as ease the burden on their caregivers. It's a home-based self-management and cognitive training intervention designed specifically for those affected by PTE.See study design
What are the potential side effects?
Since this trial involves non-medical interventions like self-management techniques and cognitive exercises, there are no direct medical side effects expected from participating in HOBSCOTCH-PTE itself.

HOBSCOTCHPTE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have epilepsy due to a past trauma, with seizures that may or may not be under control.
Select...
I feel like my memory is getting worse.
Select...
My epilepsy or depression medication hasn't changed in a month, except for EEG tests.
Select...
I can read and speak English well.
Select...
I am 18 years old or older.

HOBSCOTCHPTE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months, 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months, 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in caregiver burden as measured by comparing Zarit Burden Interview scores at baseline and at 3 months post-intervention in caregivers of PTE participants
Change in quality of life as measured by comparing QOLIE-31 scores at baseline and 3 months post-intervention in participants with PTE
Change in subjective cognition as measured by comparing NeuroQOL - Cognitive Function sub-scale scores at baseline and 3 months post-intervention in participants with PTE
Secondary outcome measures
Changes in Caregiver Participants' knowledge of epilepsy as measured by comparing scores on the [Caregiver] General Knowledge of Epilepsy questionnaire at baseline and at 6 months-post intervention.
Changes in Caregiver Participants' mood as measured by comparing scores on the Patient Health Questionnaire (PHQ-9) at baseline and at 3 months post- intervention.
Changes in PTE Participants' mood as measured by comparing scores on the Patient Health Questionnaire (PHQ-9) at baseline and at 3 months post- intervention.
+14 more

HOBSCOTCHPTE Trial Design

4Treatment groups
Experimental Treatment
Group I: PTE Participant Group 2Experimental Treatment1 Intervention
PTE Participant Group 2 will be on a 3-month wait list after which they will receive HOBSCOTCH-PTE consisting of 1:1 sessions delivered once per week including: 1 pre-HOBSCOTCH Session (on webcam) 1 educational session (on webcam) 6 telephone sessions 1 wrap-up session (webcam or telephone)
Group II: PTE Participant Group 1Experimental Treatment1 Intervention
PTE Participant Group 1 will receive the HOBSCOTCH-PTE intervention consisting of 1:1 sessions delivered once per week including: 1 pre-HOBSCOTCH Session (on webcam) 1 educational session (on webcam) 6 telephone sessions 1 wrap-up session (webcam or telephone)
Group III: PTE Caregiver Group 2Experimental Treatment1 Intervention
Caregiver Group 2 will be on a 3 month wait list with their PTE patient after which time they will receive an adapted version of HOBSCOTCH-PTE by attending session 1 of the HOBSCOTCH-PTE (virtual) program with their PTE patient as well as guidance and instructions on utilizing quick relaxation. Caregiver Group 2 will also attend session 8 of the program with the PTE patient to focus on program wrap-up and maintenance planning.
Group IV: PTE Caregiver Group 1Experimental Treatment1 Intervention
Caregiver Group 1 will receive an adapted version of HOBSCOTCH-PTE by attending session 1 of the HOBSCOTCH-PTE (virtual) program with their PTE patient as well as guidance and instructions on utilizing quick relaxation. Caregiver Group 1 will also attend session 8 of the program with the PTE patient to focus on program wrap-up and maintenance planning.

Find a Location

Who is running the clinical trial?

United States Department of DefenseFED
859 Previous Clinical Trials
225,441 Total Patients Enrolled
2 Trials studying Epilepsy
237 Patients Enrolled for Epilepsy
Dartmouth-Hitchcock Medical CenterLead Sponsor
522 Previous Clinical Trials
2,542,304 Total Patients Enrolled
11 Trials studying Epilepsy
960 Patients Enrolled for Epilepsy
Barbara C. Jobst, MD, Dr. Med.Principal InvestigatorDartmouth-Hitchcock Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many enrollees have signed up for this research endeavor?

"Verified. The information found on clinicaltrials.gov reveals that this medical study, which was first published on March 21st 2022, is actively recruiting participants. Approximately 190 individuals must be recruited from a single centre in order to complete the trial."

Answered by AI

What is the prime objective of this clinical trial?

"This trial will be evaluated over a Baseline and 3 months post-intervention period with the main goal of assessing Change in subjective cognition using NeuroQOL - Cognitive Function sub-scale scores. Secondary outcomes include shifts in Caregiver Participants' mood as measured by PHQ-9, PTE participant knowledge of their own epilepsy assessed via Epilepsy Knowledge of Own Condition questionnaire, and PTE participants self-efficacy captured through Epilepsy Self-Efficacy Scale at baseline and 6 month intervals."

Answered by AI

Are new participants sought for this clinical investigation?

"As documented on clinicaltrials.gov, this medical experiment is still recruiting participants. Its initial posting was dated March 21st 2022 with the most recent update being November 6th 2022."

Answered by AI
~15 spots leftby Jun 2024